KITLG and breast cancer: In cases where the defect in Sertoli cells is identified through whole-exon sequencing and cross-referencing with known Sertoli essential genes (eg. KITL), it could be corrected via CRISPR-mediated genome editing strategies in iPSCs prior to transplantation following BC depletion.